The first Tempest Therapeutics trade was made in Q2 2021.
Since then Jim Simons bought shares four more times and sold shares on six occasions. The investor completely sold their stake between Q3 2023 and Q4 2023.
Avg closing price
Price range
Sold -6.81k shares
Q4 2023
Avg closing price
$4.00
Price range
$2.82
-
$9.77
Sold 14.4% shares (-1.15k shares)
Q3 2023
Avg closing price
$9.60
Price range
$3.96
-
$18.07
Increased shares by 290.2% (+5.92k shares)
Q2 2023